LHC Group Receives a Rating Update from a Top Analyst

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on LHC Group (NASDAQ: LHCG) today. The company’s shares opened today at $73.55.

According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of 14.6% and a 71.1% success rate. Wiederhorn covers the Services sector, focusing on stocks such as Cross Country Healthcare, Addus Homecare Corp, and Envision Healthcare.

Currently, the analyst consensus on LHC Group is Strong Buy and the average price target is $80.75, representing a 9.8% upside.

In a report issued on April 17, SunTrust Robinson also reiterated a Buy rating on the stock with a $85 price target.

See today’s analyst top recommended stocks >>

Based on LHC Group’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $292 million and quarterly net profit of $18.44 million. In comparison, last year the company earned revenue of $247 million and had a net profit of $9.47 million.

Based on the recent corporate insider activity of 37 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Community-Based Services and Facility-Based Services.